These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38908296)

  • 1. The impact of six-week dihydrogen-pyrroloquinoline quinone supplementation on mitochondrial biomarkers, brain metabolism, and cognition in elderly individuals with mild cognitive impairment: a randomized controlled trial.
    Baltic S; Nedeljkovic D; Todorovic N; Ranisavljev M; Korovljev D; Cvejic J; Ostojic J; LeBaron TW; Timmcke J; Stajer V; Ostojic SM
    J Nutr Health Aging; 2024 Jun; 28(8):100287. PubMed ID: 38908296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Dietary Pyrroloquinoline Quinone Disodium Salt on Cognitive Function in Healthy Volunteers: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study.
    Shiojima Y; Takahashi M; Takahashi R; Moriyama H; Bagchi D; Bagchi M; Akanuma M
    J Am Nutr Assoc; 2022; 41(8):796-809. PubMed ID: 34415830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid with or without vitamin B12 for cognition and dementia.
    Malouf M; Grimley EJ; Areosa SA
    Cochrane Database Syst Rev; 2003; (4):CD004514. PubMed ID: 14584018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate: a multicenter, double-blind, randomized, placebo-controlled trial.
    De Jesus Moreno Moreno M
    Clin Ther; 2003 Jan; 25(1):178-93. PubMed ID: 12637119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medium-chain triglycerides improved cognition and lipid metabolomics in mild to moderate Alzheimer's disease patients with APOE4
    Xu Q; Zhang Y; Zhang X; Liu L; Zhou B; Mo R; Li Y; Li H; Li F; Tao Y; Liu Y; Xue C
    Clin Nutr; 2020 Jul; 39(7):2092-2105. PubMed ID: 31694759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Donepezil for dementia due to Alzheimer's disease.
    Birks JS; Harvey RJ
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD001190. PubMed ID: 29923184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Group- and Home-Based Cognitive Intervention for Patients with Mild Cognitive Impairment: A Randomized Controlled Trial.
    Jeong JH; Na HR; Choi SH; Kim J; Na DL; Seo SW; Chin J; Park SA; Kim EJ; Han HJ; Han SH; Yoon SJ; Lee JH; Park KW; Moon SY; Park MH; Choi MS; Han IW; Lee JH; Lee JS; Shim YS; Kim JY
    Psychother Psychosom; 2016; 85(4):198-207. PubMed ID: 27230861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the Antioxidant Supplement Pyrroloquinoline Quinone Disodium Salt (BioPQQ™) on Cognitive Functions.
    Itoh Y; Hine K; Miura H; Uetake T; Nakano M; Takemura N; Sakatani K
    Adv Exp Med Biol; 2016; 876():319-325. PubMed ID: 26782228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of pyrroloquinoline quinone disodium salt on brain function and physiological processes.
    Ikemoto K; Mohamad Ishak NS; Akagawa M
    J Med Invest; 2024; 71(1.2):23-28. PubMed ID: 38735721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Pyrroloquinoline Quinone (PQQ) Supplementation on Aerobic Exercise Performance and Indices of Mitochondrial Biogenesis in Untrained Men.
    Hwang PS; Machek SB; Cardaci TD; Wilburn DT; Kim CS; Suezaki ES; Willoughby DS
    J Am Coll Nutr; 2020 Aug; 39(6):547-556. PubMed ID: 31860387
    [No Abstract]   [Full Text] [Related]  

  • 13. Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial.
    Quinn JF; Raman R; Thomas RG; Yurko-Mauro K; Nelson EB; Van Dyck C; Galvin JE; Emond J; Jack CR; Weiner M; Shinto L; Aisen PS
    JAMA; 2010 Nov; 304(17):1903-11. PubMed ID: 21045096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trial.
    Henderson ST; Vogel JL; Barr LJ; Garvin F; Jones JJ; Costantini LC
    Nutr Metab (Lond); 2009 Aug; 6():31. PubMed ID: 19664276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of macular xanthophyll supplementation on brain-derived neurotrophic factor, pro-inflammatory cytokines, and cognitive performance.
    Stringham NT; Holmes PV; Stringham JM
    Physiol Behav; 2019 Nov; 211():112650. PubMed ID: 31425700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metal protein attenuating compounds for the treatment of Alzheimer's dementia.
    Sampson EL; Jenagaratnam L; McShane R
    Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD005380. PubMed ID: 24563468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Idalopirdine as Adjunct to Cholinesterase Inhibitors on Change in Cognition in Patients With Alzheimer Disease: Three Randomized Clinical Trials.
    Atri A; Frölich L; Ballard C; Tariot PN; Molinuevo JL; Boneva N; Windfeld K; Raket LL; Cummings JL
    JAMA; 2018 Jan; 319(2):130-142. PubMed ID: 29318278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study.
    Doody RS; Gavrilova SI; Sano M; Thomas RG; Aisen PS; Bachurin SO; Seely L; Hung D;
    Lancet; 2008 Jul; 372(9634):207-15. PubMed ID: 18640457
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.